Biweekly Irinotecan and Cisplatin as Second-line Chemotherapy in Pretreated Patients with Advanced Gastric Cancer: A Multicenter Phase II Study

The current phase II study was conducted to evaluate the response rate and safety of a combination regimen of biweekly irinotecan plus cisplatin in pretreated patients with advanced gastric cancer. Patients with previously treated metastatic or recurrent gastric cancer received intravenous irinoteca...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Jin Ho, Kim, Jong Gwang, Sohn, Sang Kyun, Kim, Dong Hwan, Lee, Kyu Bo, Song, Hong Suk, Kwon, Ki Young, Do, Young Rok, Ryoo, Hun Mo, Bae, Sung Hwa, Park, Keon Uk, Kim, Min Kyoung, Lee, Kyung Hee, Hyun, Myung Soo, Chung, Ho Young, Yu, Wansik
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2005
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779328/
https://www.ncbi.nlm.nih.gov/pubmed/16361806
http://dx.doi.org/10.3346/jkms.2005.20.6.966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779328/
https://www.ncbi.nlm.nih.gov/pubmed/16361806
http://dx.doi.org/10.3346/jkms.2005.20.6.966

Ejemplares similares